Eli Lilly's recent launch of Mounjaro (tirzepatide) in India has sparked significant interest especially among those looking for weight loss and diabetes control.
Social media is buzzing with discussions—some calling it a game-changer, others debating side effects. While it’s not a magic fix, its rising popularity proves India is ready for cutting-edge solutions in health and fitness.
